TECH FY 2014 Earnings Report — Bio-Techne Corporation Revenue & Financial Results | Market Cap Arena

Bio-Techne CorporationTECH

FY 2014 Earnings

Reported August 29, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$358M	—	$311M	—	15.2%
Op. Income	$160M	—	$158M	—	0.8%
Gross Margin	70.3%	—	74.4%	—	-4.1pp
Net Margin	31.0%	—	36.2%	—	-5.2pp
EPS (Diluted)	$0.75	—	$0.76	—	-1.3%
Free Cash Flow	$123M	—	$101M	—	21.6%

Revenue Flow

Item	Amount
REVENUE	$358M
Cost of Revenue	$106M
GROSS PROFIT	$251M
R&D Expenses	$31M
Selling & Marketing	$0
General & Administrative	$61M
SG&A Expenses	$61M
Other Expenses	$0
Operating Expenses	$92M
Cost & Expenses	$198M
OPERATING INCOME	$160M
Interest Income	$3M
Interest Expense	$0
Other Income/Expenses	$2M
INCOME BEFORE TAX	$161M
Income Tax Expense	$50M
Net Income from Continuing Ops	$111M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$111M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$111M
D&A	$19M
EBIT	$161M
EBITDA	$181M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$358M
Cost of Revenue	$106M
GROSS PROFIT	$251M
R&D Expenses	$31M
Selling & Marketing	$0
General & Administrative	$61M
SG&A Expenses	$61M
Other Expenses	$0
Operating Expenses	$92M
Cost & Expenses	$198M
OPERATING INCOME	$160M
Interest Income	$3M
Interest Expense	$0
Other Income/Expenses	$2M
INCOME BEFORE TAX	$161M
Income Tax Expense	$50M
Net Income from Continuing Ops	$111M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$111M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$111M
D&A	$19M
EBIT	$161M
EBITDA	$181M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$111M
Depreciation & Amortization	$19M
Stock-Based Compensation	$4M
Deferred Income Tax	-$3M
Other Non-Cash Items	$8M
Change in Working Capital	-$2M
OPERATING CASH FLOW	$137M
Capital Expenditure	-$14M
Acquisitions (Net)	-$119M
Purchases of Investments	-$107M
Sales/Maturities of Investments	$289M
Other Investing Activities	$25.0K
NET CASH FROM INVESTING	$50M
Net Debt Issuance	$0
Common Stock Repurchased	$0
Common Dividends Paid	-$45M
Other Financing Activities	$9M
NET CASH FROM FINANCING	-$37M
FREE CASH FLOW	$123M
Net Change in Cash	$155M

Balance Sheet

Item	Amount
Cash & Equivalents	$319M
Short-Term Investments	$45M
Net Receivables	$55M
Inventory	$39M
Other Current Assets	$12M
TOTAL CURRENT ASSETS	$469M
PP&E (Net)	$117M
Goodwill	$151M
Intangible Assets	$109M
Long-Term Investments	$4M
Tax Assets	$10M
Other Non-Current Assets	$3M
TOTAL NON-CURRENT ASSETS	$393M
TOTAL ASSETS	$862M
Account Payables	$10M
Short-Term Debt	$6M
Deferred Revenue	-$10M
Other Current Liabilities	$0
TOTAL CURRENT LIABILITIES	$26M
Long-Term Debt	$7M
Deferred Revenue NC	-$4M
Deferred Tax Liabilities	$34M
Other Non-Current Liabilities	$0
TOTAL NON-CURRENT LIABILITIES	$41M
TOTAL LIABILITIES	$67M
Common Stock	$370.0K
Additional Paid-In Capital	$147M
Retained Earnings	$653M
Treasury Stock	$0
Accum. Other Comp. Income	-$5M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$795M
Minority Interest	$0
TOTAL EQUITY	$795M
TOTAL LIABILITIES & EQUITY	$862M
Total Debt	$13M
Net Debt	-$306M